Stanislav Glezer
Chief Tech/Sci/R&D Officer at INOGEN, INC.
Net worth: 129 975 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kevin Smith | M | 53 | 1 years | |
| Elizabeth Mora | F | 63 | 3 years | |
| Kevin King | M | 67 | 2 years | |
| Thomas West | M | 60 | 1 years | |
| Heather Rider | F | 65 | 10 years | |
| Mary Ladone | F | 57 | 2 years | |
| Glenn Boehnlein | M | 62 | 2 years | |
| Jason Somer | M | 56 | 3 years | |
| Gregoire Ramade | M | 54 | 1 years | |
| Michelle Quinn | F | 56 | 5 years | |
| Tara Charvat | F | - |
Diabetes Foundation of New Jersey
| - |
| Antoine Ezell | M | 55 | 4 years | |
| Elizabeth McCombs | F | 48 | 5 years | |
| Brooke Story | F | 52 | 6 years | |
| Jennifer M. Yi Boyer | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alison Bauerlein | F | 42 | 20 years | |
| Nabil Shabshab | M | 58 | 12 years | |
| Vincent Forlenza | M | 70 | 41 years | |
| Michael Sergesketter | M | 64 | 3 years | |
| Raymond O. Huggenberger | M | 65 | 13 years | |
| Kristin Caltrider | F | 56 | 1 years | |
| Heath Lukatch | M | 57 | 16 years | |
| John Gallagher | M | 51 | - | |
| George Parr | M | 53 | 6 years | |
| Nina Elizabeth Woodard | F | - |
California Coast University
| 15 years |
| Linda Tharby | F | 56 | - | |
| Gary A. Mecklenburg | M | 78 | 15 years | |
| Monique N. Dolecki | F | - | 7 years | |
| Kristen Miranda | F | 62 | 2 years | |
| Loren McFarland | M | 65 | 9 years | |
| Brenton Taylor | M | 42 | 21 years | |
| David Highet | M | - | - | |
| John DeFord | M | 62 | 4 years | |
| Benjamin M. Anderson-Ray | M | 69 | 9 years | |
| Kristen Stewart | F | - | 2 years | |
| Willard Overlock | M | 78 | 20 years | |
| Lisa McCann | F | 42 | 4 years | |
| Tobi Karchmer | M | - | 12 years | |
| Jerry Flasz | M | - | - | |
| Duncan Fatkin | M | - | 2 years | |
| Michael S. Simpson | M | 57 | 1 years | |
| Neena Patil | F | 49 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 8 years |
| Bart Sanford | M | 58 | 5 years | |
| Jacob Elguicze | M | 51 | 1 years | |
| Charles R. Bodner | M | - | - | |
| Linda J. Peters | F | - | 2 years | |
| Kristen L. Cardillo | F | - | 6 years | |
| Joseph Kelly | M | 55 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 15 years |
| Tariq Arshad | M | 54 | 2 years | |
| Devdatt Kurdikar | M | 56 | 1 years | |
| Stephen Gunstream | M | 45 | 4 years | |
| Jacqueline Scanlan | F | 51 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 2 years |
| Agnes Lee | F | - | 1 years | |
| Jesper Høiland | M | 63 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 30 years |
| Edward Williams | M | 68 |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | 11 years |
| James Borzi | M | 61 | 6 years | |
| Steven J. Burchell | M | - |
California Coast University
| 1 years |
| Patrick Kaltenbach | M | 60 | 3 years | |
| Steven Williamson | M | 51 | 2 years | |
| Brent Ashton | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 60 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stanislav Glezer
- Personal Network
